Orthofix International | OFIX - Cash And Equivalent


Orthofix International reported $120.28M in Cash and Equivalent for its fiscal quarter ending in March of 2026.





Cash And Equivalent Change Date
Accuray USD 63.34M 5.93M Sep/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Artivion USD 64.91M 8.52M Dec/2025
AtriCure USD 167.43M 19.56M Dec/2025
Dexcom USD 1.12B 200.5M Mar/2026
EDAP TMS EUR 29.84M 4.35M Dec/2024
Globus Medical USD 526.16M 154.39M Dec/2025
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 236.81M 1.76M Mar/2026
J&J USD 21.69B 1.98B Mar/2026
Medtronic USD 1.15B 135M Dec/2025
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 120.28M 38.25M Mar/2026
Plus Therapeutics USD 4.26M 9.03M Dec/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Stryker USD 2.88B 1.13B Mar/2026
Surmodics USD 36.11M 11.81M Sep/2024
Tandem Diabetes Care USD 90.63M 1.31M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Veracyte USD 362.58M 47M Dec/2025
Zimmer Biomet Holdings USD 424.2M 167.7M Mar/2026